Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults
Author(s) -
Robyn L. Woods,
Sara Espinoza,
Lê Thị Phương Thảo,
Michael E. Ernst,
Joanne Ryan,
Rory Wolfe,
Raj C. Shah,
Stéphanie Ward,
Elsdon Storey,
Mark Nelson,
Christopher M. Reid,
Jessica E. Lockery,
Suzanne G. Orchard,
Ruth E. Trevaks,
Sharyn M. Fitzgerald,
Nigel Stocks,
Jeff D. Williamson,
John J. McNeil,
Anne M. Murray,
Anne B. Newman
Publication year - 2020
Publication title -
the journals of gerontology series a
Language(s) - English
Resource type - Journals
eISSN - 1758-535X
pISSN - 1079-5006
DOI - 10.1093/gerona/glaa316
Subject(s) - aspirin , activities of daily living , medicine , hazard ratio , bathing , placebo , confidence interval , proportional hazards model , physical therapy , dementia , gerontology , disease , alternative medicine , pathology
Cerebrovascular events, dementia, and cancer can contribute to physical disability with activities of daily living (ADL). It is unclear whether low-dose aspirin reduces this burden in aging populations. In a secondary analysis, we now examine aspirin's effects on incident and persistent ADL disability within a primary prevention aspirin trial in community-dwelling older adults.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom